Economy

Swiss study finds chronic pain alters structure of brain

Chronic pain alters the structure of the brain

This content was published on Aug 27, 2026 Swiss researchers have found links between chronic pain and brain structure changes that could help with better pain management.

New treatments

Swiss non-profit drugmakers team up as funding shrinks

This content was published on Aug 25, 2026 Waning commitments to global health causes and big pharma’s financial imperatives are threatening the development of innovative drugs to help patients left on the sidelines of medicine.

Roche acquires rights to an experimental treatment for obesity

Healthcare innovation

Roche snags rights to South Korean obesity treatment

This content was published on Aug 24, 2026 Roche subsidiary secures global rights to manufacture South Korean obesity treatment.

Medicine access

US price pressure ‘threatens new drugs’ in Switzerland

This content was published on Aug 24, 2026 Boss of Swiss pharma research association bemoans political pressure of drug prices.

Hearing with AI: Sonova is focusing on the next generation

Healthcare innovation

Swiss hearing aid specialist Sonova launching new AI devices

This content was published on Aug 24, 2026 Swiss hearing aid manufacturer Sonova launching new devices powered by artificial intelligence.

The grape harvest in 2026 will begin around three weeks earlier than usual

Agribusiness

Swiss grape harvest begins earlier than usual

This content was published on Aug 22, 2026 Swiss winegrowers begin the 2026 grape harvest weeks early, with drought shrinking grapes.

CSL Behring is cutting fewer than ten per cent of its jobs

Workplace

Pharma firm CSL Behring cuts around 10% of workforce in Bern

This content was published on Aug 20, 2026 The Australian pharmaceutical group CSL Behring has cut just under 10% of the workforce in Bern.

Pharma supply chains

Swiss exports rebounded in July driven by pharma sector

This content was published on Aug 20, 2026 Switzerland’s foreign trade rebounded in July, with exports showing strong growth following a decline the previous month.

"Hallucinogenic mushrooms": what really happens in the brain

New treatments

Study explains what psilocybin does to the brain

This content was published on Aug 20, 2026 A study involving the University of Zurich has found that "magic mushrooms" direct brain activity more decisively towards the present.

The average cost of developing a new drug, from discovery to launch, reached $2.23 billion in 2024 for the world's 20 biggest biopharma companies – a 65% jump from 2014.

Healthcare innovation

Why drugs are becoming more expensive to develop

This content was published on Aug 18, 2026 Drug development has always been expensive and risky, but now it’s measurably more so than a decade ago. Here are three reasons why.

Page 9 of 51

First … 7 8 9 10 11 … Last

Economy

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Economy

More

Swiss study finds chronic pain alters structure of brain

More

Swiss non-profit drugmakers team up as funding shrinks

More

Roche snags rights to South Korean obesity treatment

More

US price pressure ‘threatens new drugs’ in Switzerland

More

Swiss hearing aid specialist Sonova launching new AI devices

More

Swiss grape harvest begins earlier than usual

More

Pharma firm CSL Behring cuts around 10% of workforce in Bern

More

Swiss exports rebounded in July driven by pharma sector

More

Study explains what psilocybin does to the brain

More

Why drugs are becoming more expensive to develop

Popular Stories

Most Discussed